Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc Analysis From the Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial (IDNT)
Lambers Heerspink, Hiddo J., Weldegiorgis, Misghina, Inker, Lesley A., Gansevoort, Ron, Parving, Hans-Henrik, Dwyer, Jamie P., Mondal, Hasi, Coresh, Josef, Greene, Tom, Levey, Andrew S., de Zeeuw, DicVolume:
63
Language:
english
Journal:
American Journal of Kidney Diseases
DOI:
10.1053/j.ajkd.2013.09.016
Date:
February, 2014
File:
PDF, 630 KB
english, 2014